Daily Newsletter

28 August 2023

Daily Newsletter

28 August 2023

Cincinnati Children’s to open mental health facility in College Hill

The new centre is said to be the largest inpatient mental health provider among children’s hospitals in the US.

August 28 2023

Cincinnati Children's Hospital Medical Center is set to launch a new mental health facility, named the William K. Schubert, M.D., Mental Health Center, reported cincinnati.com.

Located in College Hill, the new centre is said to be the largest inpatient mental health provider among US children’s hospitals.

It is over two-thirds bigger than the previous centre and features 83 private patient rooms with overnight accommodations for families.

Construction on the project began in May 2021. This 160,000ft2 expansion was carried out using the $30m donation from the Convalescent Hospital Fund for Children, with the total project entailing an investment of $108m.

The centre’s design includes a Family Resource Center, an enhanced educational centre, as well as therapeutic treatment spaces.

According to the news publication, the facility’s opening coincides with a rise in mental health concerns among youth across the US.

Cincinnati Children’s president and CEO Dr. Steve Davis was quoted as saying by the publication: “Paediatric mental illness is one of the most pressing health issues of our time.

“These children deserve our best ideas, our most courageous strategies, our long-term commitment, and our utmost compassion.

“With the opening of this facility, we have another tremendous opportunity to make a difference in the lives of our patients, families and staff in terms of improved access and the quality of care we deliver.”

Digital transformation of the healthcare industry is driving the demand and development for precision and personalized medicine

Per GlobalData estimates, the precision and personalized medicine market is expected to achieve a CAGR of more than 43% between 2022 and 2029. The digital transformation of the healthcare industry is driving the market demand. For example, advances in biomarker testing with NGS are improving patient selection, use of AI in identifying trends in big datasets is accelerating the time from drug discovery to commercialization, and the use of Industry 4.0 technologies is improving the quality and efficiency of manufacturing complex drugs such as cell and gene therapies.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close